TriangleNCT00602446 · OUTCOME
Number of Patients Not Completing Treatment
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 6 Months
What was measured
Number of patients who discontinued deferasirox during 6 month daily treatment due to drug related toxicity
Analysis population: Note: 1 patient had a transient decrease in hemoglobin that required discontinuation of treatment for 2 weeks; subsequently restarted at same dose and completed therapy.
Groups in this outcome
Deferasirox Treated
Includes patients that were treated with deferasirox for 6 months.
| Group | Source count |
|---|---|
| Deferasirox Treated | 3 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Deferasirox Treated | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- anticipated Posting Date
- 2010-03
- classes
- categories
- measurements
- group Id
- OG000
- value
- 0
- denoms
- counts
- group Id
- OG000
- value
- 3
- units
- Participants
- description
- Number of patients who discontinued deferasirox during 6 month daily treatment due to drug related toxicity
- groups
- description
- Includes patients that were treated with deferasirox for 6 months.
- id
- OG000
- title
- Deferasirox Treated
- param Type
- NUMBER
- population Description
- Note: 1 patient had a transient decrease in hemoglobin that required discontinuation of treatment for 2 weeks; subsequently restarted at same dose and completed therapy.
- reporting Status
- POSTED
- time Frame
- 6 Months
- title
- Number of Patients Not Completing Treatment
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice